Press-July, 6 2020

Synapse Medicine raises 8 million dollars to prevent drug-related risks everywhere in the world

Synapse Medicine has announced that it has raised 8 million dollars, spearheaded by the MACSF, a leading insurance provider for healthcare professionals, and with the support of XAnge, BNP Paribas, BPI, and Nicolas Dessaigne, co-founder of Algolia. The purpose of this move is to continue the development of its leading-edge medication intelligence platform, which is already being used by thousands of healthcare professionals and patients daily. The company has now raised 11 million dollars over a 14-month period and tripled the size of its staff.  

The Gustave Roussy Institute Integrates Synapse Platform

France’s Gustave Roussy Institute, Europe's leading cancer center and ranked third in the world according to Newsweek Ma…

Synapse Medicine Initiates Multi-Site Implementation Study with Leading U.S Hospitals

Synapse Medicine clinical decision support technology analyzes drug-related risks based on each patient’s clinical chara…

Synapse Medicine raises $28M to scale its medication reconciliation platform

Synapse Medicine has raised $28 million, led by leading European venture firm Korelya Capital, and past investors (XAnge…

Synapse Medicine and Dedalus partner on Medication Reconciliation

Synapse Medicine, the leading Medication Intelligence technology, announces a partnership on medication reconciliation w…

COVID-19 vaccination campaign safety : France rolls out the "Medication Shield" of Synapse Medicine.

Synapse Medicine, which was founded by public health physicians, rolls out its Medication Shield technology to increase …

Synapse Medicine raises 8 million dollars to prevent drug-related risks everywhere in the world

Synapse Medicine has announced that it has raised 8 million dollars, spearheaded by the MACSF, a leading insurance provi…

They talk about us

Synapse Medicine enters clinical trial for COVID-19

Synapse Medicine enters clinical trial for COVID-19